No products
Product successfully added to your shopping cart
There are 0 items in your cart. There is 1 item in your cart.
View larger
Tirzepatide 5mg
-
Tirzepatide is a novel dual-agonist developed by Eli Lilly and Co. with the purpose of harnessing the potential of two naturally occurring incretin hormones: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
- Found a lower price? Contact us and we give you a better deal!
---100 eur per vial if you buy 5+ vial---90 eur per vial if you buy 10+ vials----80 eur per vial if you buy 20+ vials---
- Write a review
Volume discounts
| Quantity | Price | You Save |
|---|---|---|
| 5 | 100,00 € | Up to 50,00 € |
| 10 | 90,00 € | Up to 200,00 € |
| 20 | 80,00 € | Up to 600,00 € |
More info
About Tirzepatide
The digestive tract releases these incretin hormones to stimulate insulin release in response to food intake [2]. Structurally, tirzepatide is composed of 39 amino acids, featuring a modified GIP sequence at the N-terminus and a C-terminus sequence derived from the GLP-1 agonist exenatide.
The effects of the use of Tirzepatide
Improved glycemic control
Weight loss
Nonalcoholic fatty liver disease
Improving of sleep quality
Low risk of thyroid C cell tumors
Application and dosage of Tirzepatide
The peptide is administered subcutaneous injection. The weekly dosage is calculated according to the attached instructions and is 2.5 mg a week
To prepare the solution the peptide is diluted with injection water and can be stored in the refrigerator up to 10 days.
Application information is posted for the informational purposes only.
Found a lower price? Contact us and we give you a better deal!